Partnering in the Discovery & Development of Novel Biotherapeutics: A Perspective from Cancer Research UK
Robert Williams,
Chief Development Scientist,
Cancer Research UK
Cancer Research UK is the world’s largest charitable funder of cancer
research. The organization has a long history of supporting the
discovery and development of novel anti-cancer medicines. CRUK works
extensively with academic institutes, biotechnology and pharmaceutical
companies utilising a wide range of partnering arrangements and business
frameworks. This presentation will describe examples of innovative
collaborations in the discovery and development of new antibody-based
therapeutics.
|
|
